Comparison · NCT03129321-6cc3e7ca
Test vs Reference Standard: Proportion of Patients in Each Active Treatment Group Who Are Considered a Mycological Cure
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Test vs Reference Standard: Proportion of Patients in Each Active Treatment Group Who Are Considered a Mycological Cure. Trial comparisons, record NCT03129321-6cc3e7ca. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03129321-6cc3e7ca
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.735 | 0.667 | 0.793 | wilson | |
| Risk in group 2 | 0.735 | 0.664 | 0.796 | wilson | |
| Risk difference, group 1 minus group 2 | -0.000159 | -0.0912 | 0.0917 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1 | 0.882 | 1.13 | log | |
| Odds ratio, group 1 over group 2 | 0.999 | 0.623 | 1.6 | log | |
| Number needed to treat, for one fewer participant with the outcome on Test than on Reference Standard | 6,290 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Test | Econazole Nitrate Cream, 1%, topical, sufficient amount to cover all affected areas on the feet once daily for 28 days~Econazole Nitrate Cream, 1% | 136 | 185 | OG000 |
| Group 2 | Reference Standard | Econazole Nitrate Cream, 1%, topical, sufficient amount to cover all affected areas on the feet once daily for 28 days~Econazole Nitrate Cream, 1% | 125 | 170 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Proportion of Patients in Each Active Treatment Group Who Are Considered a Mycological Cure
- Description
- To be considered a mycological cure the patient must have a negative KOH test and a negative fungal culture for T. rubrum, T. mentagrophytes or E. floccosum
- Time frame
- Day 42
- Population
- Active treatment groups of the Per Protocol population
Source ClinicalTrials.gov
Trial
- Title
- Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis
- NCT number
- NCT03129321
- Phases
- PHASE3
- Conditions
- Tinea Pedis
- Interventions
- Econazole Nitrate Cream, 1%, Placebo
- Lead sponsor
- Mylan Inc.
- Results first posted
- 2018-08-02
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03129321?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03129321-6cc3e7ca